HUP0401967A2 - Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására - Google Patents
Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP0401967A2 HUP0401967A2 HU0401967A HUP0401967A HUP0401967A2 HU P0401967 A2 HUP0401967 A2 HU P0401967A2 HU 0401967 A HU0401967 A HU 0401967A HU P0401967 A HUP0401967 A HU P0401967A HU P0401967 A2 HUP0401967 A2 HU P0401967A2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- acetylcholine receptor
- restless legs
- legs syndrome
- preparation
- Prior art date
Links
- 208000005793 Restless legs syndrome Diseases 0.000 title abstract 4
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- QFBCQOXKGBYUSU-UHFFFAOYSA-M 2-acetyloxyethyl(trimethyl)azanium;pyridine-3-carboxylate Chemical compound [O-]C(=O)C1=CC=CN=C1.CC(=O)OCC[N+](C)(C)C QFBCQOXKGBYUSU-UHFFFAOYSA-M 0.000 abstract 2
- 229940122578 Acetylcholine receptor agonist Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
A találmány tárgya eljárás nyugtalanláb szindrómától szenvedő alanykezelésére, amely szerint az ilyen kezelésre szoruló alanynak egynikotinsav-acetilkolin-receptor-agonistának a szindróma kezeléséhezhatásos mennyiségét adják be. A találmány tárgya továbbá nikotinsav-acetilkolin-receptor-agonista vegyület vagy annak gyógyászatilagelfogadható sója alkalmazása nyugtalanláb szindróma (RLS) kezeléséreszolgáló gyógyszer előállítására. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33481001P | 2001-10-31 | 2001-10-31 | |
| US33585801P | 2001-11-26 | 2001-11-26 | |
| PCT/IB2002/004379 WO2003037329A1 (en) | 2001-10-31 | 2002-10-21 | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0401967A2 true HUP0401967A2 (hu) | 2005-01-28 |
Family
ID=26989404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401967A HUP0401967A2 (hu) | 2001-10-31 | 2002-10-21 | Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1439836A1 (hu) |
| JP (1) | JP2005507411A (hu) |
| KR (1) | KR20050038583A (hu) |
| CN (1) | CN1568184A (hu) |
| BR (1) | BR0213696A (hu) |
| CA (1) | CA2460118A1 (hu) |
| CZ (1) | CZ2004524A3 (hu) |
| HU (1) | HUP0401967A2 (hu) |
| IL (1) | IL160967A0 (hu) |
| MX (1) | MXPA04002539A (hu) |
| PL (1) | PL370549A1 (hu) |
| SK (1) | SK1912004A3 (hu) |
| TW (1) | TW200300139A (hu) |
| WO (1) | WO2003037329A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05012507A (es) * | 2003-05-20 | 2006-01-30 | Pfizer Prod Inc | Composiciones farmaceuticas de vareniclina. |
| EP1677812A4 (en) | 2003-09-17 | 2010-03-24 | Xenoport Inc | TREATMENT OR PREVENTION OF NON-REST LEG SYNDROME USING GABA ANALOGUE-BASED PRODRUGS |
| EP1934174B1 (en) | 2005-10-07 | 2011-04-06 | Exelixis, Inc. | Azetidines as mek inhibitors for the treatment of proliferative diseases |
| CA2671982C (en) | 2006-12-14 | 2016-01-26 | Exelixis, Inc. | Methods of using mek inhibitors |
| JP6272857B2 (ja) * | 2012-07-27 | 2018-01-31 | ニューロダイン ライフ サイエンシズ インコーポレイテッドＮｅｕｒｏｄｙｎ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． | 選ばれた処方物によるガランタミンの向上した脳バイオアベイラビリティおよび親油性プロドラッグの経粘膜投与 |
| ES2880399T3 (es) | 2012-07-27 | 2021-11-24 | Neurodyn Life Sciences Inc | Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos |
| GEP201706690B (en) | 2012-10-12 | 2017-06-26 | Exelixis Inc | Novel process for making compounds for use in treatment of cancer |
| US10568852B2 (en) * | 2015-05-22 | 2020-02-25 | Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) | Combination compositions and their use in methods for treating obesity and obesity-related disorders |
| WO2018236957A1 (en) * | 2017-06-20 | 2018-12-27 | Nexien Biopharma, Inc. | METHOD AND COMPOSITIONS FOR TREATING REST-FREE LEG SYNDROME |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020335A (en) * | 1997-02-06 | 2000-02-01 | Pfizer Inc | (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| US5977131A (en) * | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
| US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
| EP0955301A3 (en) * | 1998-04-27 | 2001-04-18 | Pfizer Products Inc. | 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors |
| ATE258921T1 (de) * | 1998-04-29 | 2004-02-15 | Pfizer Prod Inc | Aryl-annellierte azapolycyclische verbindungen |
-
2002
- 2002-10-21 CZ CZ2004524A patent/CZ2004524A3/cs unknown
- 2002-10-21 IL IL16096702A patent/IL160967A0/xx unknown
- 2002-10-21 CN CNA028200292A patent/CN1568184A/zh active Pending
- 2002-10-21 MX MXPA04002539A patent/MXPA04002539A/es unknown
- 2002-10-21 PL PL02370549A patent/PL370549A1/xx not_active Application Discontinuation
- 2002-10-21 KR KR1020047006544A patent/KR20050038583A/ko not_active Application Discontinuation
- 2002-10-21 CA CA002460118A patent/CA2460118A1/en not_active Abandoned
- 2002-10-21 EP EP02802239A patent/EP1439836A1/en not_active Withdrawn
- 2002-10-21 JP JP2003539673A patent/JP2005507411A/ja active Pending
- 2002-10-21 HU HU0401967A patent/HUP0401967A2/hu unknown
- 2002-10-21 BR BR0213696-1A patent/BR0213696A/pt not_active IP Right Cessation
- 2002-10-21 SK SK191-2004A patent/SK1912004A3/sk not_active Application Discontinuation
- 2002-10-21 WO PCT/IB2002/004379 patent/WO2003037329A1/en not_active Application Discontinuation
- 2002-10-30 TW TW091132199A patent/TW200300139A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050038583A (ko) | 2005-04-27 |
| CN1568184A (zh) | 2005-01-19 |
| WO2003037329A1 (en) | 2003-05-08 |
| MXPA04002539A (es) | 2004-05-31 |
| IL160967A0 (en) | 2004-08-31 |
| PL370549A1 (en) | 2005-05-30 |
| CA2460118A1 (en) | 2003-05-08 |
| BR0213696A (pt) | 2004-10-26 |
| TW200300139A (en) | 2003-05-16 |
| SK1912004A3 (en) | 2004-09-08 |
| JP2005507411A (ja) | 2005-03-17 |
| EP1439836A1 (en) | 2004-07-28 |
| CZ2004524A3 (cs) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA86621C2 (ru) | Антагонисты рецептора глюкагона, их получение и терапевтическое применение | |
| PT1687305E (pt) | Derivados de 1h-imidazoquinolina como inibidores de proteína quinase | |
| NO20074567L (no) | Glucagonreseptorantagoniser, fremstilling og terapeutisk anvendelse | |
| EE04911B1 (et) | Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks | |
| DK1957484T3 (da) | Glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser | |
| MX2007008614A (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r). | |
| UA83659C2 (ru) | Антагонисты рецепторов p2x7 и их применение, фармацевтическая композиция на их основе, способ их получения (варианты) | |
| JO2371B1 (en) | 4-phenyl-pyridine derivatives | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| NO20052739L (no) | CCR5-antagonister som medikamenter | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| WO2006025070A3 (en) | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol | |
| MY143466A (en) | Inhibitors of tyrosine kinases | |
| GEP20104962B (en) | Fused heterocyclic compounds | |
| WO2007120270A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
| DK1735278T3 (da) | Histamin H3-receptormidler, fremstilling og terapeutiske anvendelser | |
| PH12014500937A1 (en) | 5-ht 1a receptor substype agonist | |
| ATE383850T1 (de) | Pulver enthaltend neuartige oligosaccharidgemische und verfahren zu deren herstellung | |
| TW200631956A (en) | Azabenzoxazoles for the treatment of CNS disorders | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| DK1951659T3 (da) | Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf | |
| SE0102036D0 (sv) | Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof | |
| TW200606164A (en) | New compounds | |
| SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
| HUP0401967A2 (hu) | Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |